Ian Clark
Description Ian T. Clark, age 49, has served as one of our directors since October 2009. Mr. Clark is currently the chief executive officer and head of North American commercial operations at Genentech, a wholly-owned member of the Roche Group. Prior to January 2010, he was head of global product strategy and chief marketing officer at Roche, Pharma Division since March 2009. Mr. Clark previously was executive vice president of commercial operations since 2006, senior vice president of commercial operations since 2005, and senior vice president of oncology commercial operations for Genentech?s BioOncology business unit since 2003, which focused on global commercialization of the company?s diverse oncology pipeline, including Avastin?, Rituxan? and Herceptin?. Prior to his time at Genentech, Mr. Clark was president of Novartis Canada from 2001 to 2003 and chief operating officer of Novartis United Kingdom from 1999 to 2001, and also served on the Board of Directors of Vernalis, a pharmaceutical company, from 2007 to 2009. Mr. Clark?s senior management experience with a leading biotechnology company and extensive background in the commercialization of drug and treatment therapies give him desired and appropriate qualifications to serve as a member of our Board. Mr. Clark received a B.S. in biological sciences from Southampton University in the United Kingdom. To view the detailed information, you need to SUBSCRIBE with us. |
 |